Dr. D Soya, M.D.
What this data tells you about Dr. Soya
Dr. D Soya is a cardiovascular disease in Amarillo, TX, with 20 years in practice. Based on federal Medicare data, Dr. Soya performed 13,007 Medicare services across 6,216 unique beneficiaries.
Between the years covered by Open Payments, Dr. Soya received a total of $1,684 from 16 pharmaceutical and/or device companies across 79 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Soya is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 2,711 | $0 | $2 |
| Office visit, established patient (30-39 min) | 2,042 | $86 | $275 |
| Electrocardiogram (EKG), 12-lead | 1,702 | $9 | $85 |
| Regadenoson injection (Lexiscan) for heart stress test | 1,173 | $46 | $100 |
| EKG interpretation and report | 908 | $6 | $50 |
| Chronic care management, first 20 min/month | 763 | $44 | $100 |
| Anticoagulant management of patient taking warfarin | 622 | $8 | $50 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 496 | $49 | $350 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 468 | $170 | $221 |
| Echocardiogram, transthoracic | 373 | $140 | $1,410 |
| Ultrasound of both sides of head and neck blood flow | 278 | $139 | $822 |
| Hospital follow-up visit, high complexity | 248 | $93 | $216 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 179 | $1,841 | $6,500 |
| Prothrombin time test (blood clotting) | 150 | $4 | $32 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 141 | $59 | $80 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 103 | $128 | $610 |
| Hospital follow-up visit, moderate complexity | 87 | $62 | $173 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 73 | $334 | $2,205 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 67 | $86 | $410 |
| Initial hospital admission, high complexity | 67 | $136 | $475 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 55 | $1,066 | $3,800 |
| New patient office visit (45-59 min) | 50 | $112 | $295 |
| Cardiac catheterization | 43 | $790 | $9,290 |
| Office visit, established patient (20-29 min) | 27 | $65 | $200 |
| Ultrasound study of arm and leg arteries | 26 | $50 | $385 |
| Ultrasound of leg arteries or artery grafts | 25 | $180 | $875 |
| Ultrasound of heart, follow-up | 23 | $19 | $92 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 22 | $65 | $250 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 21 | $49 | $515 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 18 | $9 | $150 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 18 | $17 | $150 |
| New patient office visit (30-44 min) | 17 | $82 | $200 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 11 | $203 | $1,125 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Soya is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Soya experienced with contrast dye for imaging (iodine-based)?
Does Dr. Soya receive payments from pharmaceutical companies?
How do Dr. Soya's costs compare to other cardiovascular diseases in Amarillo?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology